MedCity News
APRIL 14, 2025
The decade ahead will test our healthcare system like never before. But within these challenges lies an opportunity to create a more accessible, effective, and sustainable healthcare system if we dare to innovate and adapt to the changing landscape. The post How Technology and Value-Based Models Will Reshape Healthcare by 2035 appeared first on MedCity News.
PharmaVoice
APRIL 14, 2025
Major changes to the dynamics of the pharmaceutical ecosystem are making executive decisions even tougher.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MedCity News
APRIL 14, 2025
Pfizer said a patient dosed with danuglipron developed potential drug-induced liver injury. Pfizer is stopping further work on this program, a move that comes nearly two years after it discontinued development of a different obesity drug due to liver safety signals in a clinical trial. The post Pfizer Stops Work on Oral GLP-1 Obesity Drug After Safety Signal Surfaces in Clinical Trial appeared first on MedCity News.
European Pharmaceutical Review
APRIL 14, 2025
New research has proposed a method to increase the effectiveness of tumour-infiltrating lymphocyte (TIL) immunotherapy. Investigators identified that the natural immune protein called CD40L was key in improving TIL cultures in the lab. We discovered that by adding CD40L to the immune cells in the lab, we could dramatically improve the number and quality of cancer-fighting T cells were able to grow, explained Daniel Abate-Daga, PhD, lead author of the study and Scientific Director of the Cell The
Advertiser: ZoomInfo
AI adoption is reshaping sales and marketing. But is it delivering real results? We surveyed 1,000+ GTM professionals to find out. The data is clear: AI users report 47% higher productivity and an average of 12 hours saved per week. But leaders say mainstream AI tools still fall short on accuracy and business impact. Download the full report today to see how AI is being used — and where go-to-market professionals think there are gaps and opportunities.
MedCity News
APRIL 14, 2025
By moving beyond adherence and drug interactions to a holistic, outcomes-driven approach, health systems and providers can redefine how medication is used not as a rigid protocol but as a dynamic, patient-centered tool for achieving better health. The post Medication Adherence and Deprescribing Programs Arent Enough for Todays Polypharmacy Patients appeared first on MedCity News.
Pharma Rep Focus brings together the best content for pharma rep professionals from the widest variety of industry thought leaders.
MedCity News
APRIL 14, 2025
About a third of small businesses discontinue their health insurance coverage from one year to the next, new research from JPMorganChase Institute shows. The post JPMorgan: How Small and Mid-Sized Businesses Make Healthcare Decisions appeared first on MedCity News.
pharmaphorum
APRIL 14, 2025
Roche has claimed a first-in-class approval in the EU for Columvi in relapsed/refractory diffuse large B-cell lymphoma (DLBCL).
PharmaTimes
APRIL 14, 2025
Birmingham researchers to make MGUS monitoring more efficient
Pharmaceutical Technology
APRIL 14, 2025
Phase Ib results show VERVE-102 reduced LDL-C levels with no serious safety issues, unlike Verves VERVE-101 programme.
Speaker: Jesse Hunter and Brynn Chadwick
Today’s buyers expect more than generic outreach–they want relevant, personalized interactions that address their specific needs. For sales teams managing hundreds or thousands of prospects, however, delivering this level of personalization without automation is nearly impossible. The key is integrating AI in a way that enhances customer engagement rather than making it feel robotic.
pharmaphorum
APRIL 14, 2025
Bristol-Myers Squibb has claimed its second FDA approval in just a few days for its Opdivo/Yervoy combination, this time in liver cancer.
PharmaTimes
APRIL 14, 2025
Major update aims to accelerate research and strengthen patient safety
Pharmaceutical Technology
APRIL 14, 2025
Sandoz is suing Amgen over alleged patent abuse delaying the US launch of a biosimilar to the autoimmune drug Enbrel.
pharmaphorum
APRIL 14, 2025
The use of AI outcome prediction models (OPMs) in medicine is on the rise, but a new paper has warned widespread use could lead to patient harm.
Advertiser: ZoomInfo
ZoomInfo customers aren’t just selling — they’re winning. Revenue teams using our Go-To-Market Intelligence platform grew pipeline by 32%, increased deal sizes by 40%, and booked 55% more meetings. Download this report to see what 11,000+ customers say about our Go-To-Market Intelligence platform and how it impacts their bottom line. The data speaks for itself!
PharmaTech
APRIL 14, 2025
Pharmaceutical Technology spoke with Alexander Seyf, CEO and co-founder of Autolomous, about the use of artificial intelligence and machine learning in pharmaceutical development and manufacturing.
Copyright Clearance Center
APRIL 14, 2025
The post American Psychological Associations Stepped Approach to Managing Responsible AI: An Interview with Aaron Wood on Employee Policies, Rights Reservation, and Research Integrity appeared first on Copyright Clearance Center.
pharmaphorum
APRIL 14, 2025
Pfizer has been forced to discontinue its oral GLP-1 receptor agonist danuglipron after seeing signs of liver toxicity in late-stage clinical testing.
PharmaTech
APRIL 14, 2025
Vitrakvi (larotrectinib) was first granted accelerated approval by FDA in November 2018.
Speaker: Kevin Burke
AI is reshaping marketing and sales, empowering professionals to work smarter, faster, and more effectively. This webinar will provide a practical introduction to AI, focusing on its current applications, transformative potential, and strategies for successful implementation in your organization. Using real-world examples and actionable insights, we’ll examine how businesses are leveraging AI to increase efficiency, enhance personalization, and drive measurable results.
Pharmaceutical Commerce
APRIL 14, 2025
How artificial intelligence tools are helping to optimize the pharmaceutical transport process.
PharmExec
APRIL 14, 2025
Approval of Opdivo plus Yervoy combination was based on results from the Phase III CheckMate-9DW trial, which demonstrated significantly improved overall survival and overall response rate in patients with unresectable or metastatic hepatocellular carcinoma.
Pharmaceutical Technology
APRIL 14, 2025
Pfizer still has another obesity pill in development, PF-07976016, which is currently in a Phase IIa trial.
PharmExec
APRIL 14, 2025
Odylia Therapeutics event brings together leaders across biotech, pharma, venture capital, patient advocacy, and research sectors to address the financial and structural barriers that impede rare disease drug development.
Advertiser: ZoomInfo
Incorporating generative AI (gen AI) into your sales process can speed up your wins through improved efficiency, personalized customer interactions, and better informed decision- making. Gen AI is a game changer for busy salespeople and can reduce time-consuming tasks, such as customer research, note-taking, and writing emails, and provide insightful data analysis and recommendations.
Pharmaceutical Commerce
APRIL 14, 2025
Exploring the importance of contract development and manufacturing organizations in advancing the latest technology for effective delivery of temperature-sensitive medicines.
Pharmaceutical Technology
APRIL 14, 2025
The chronic obstructive pulmonary disease (COPD) market across the seven major markets (7MM: US, France, Germany, Italy, Spain, UK, and Japan) is forecast to grow from $11.6bn in 2023 to $30.2bn by 2033, representing a compound annual growth rate of 10%, according to leading data and analytics company GlobalData.
Pharmaceutical Commerce
APRIL 14, 2025
In the second part of his video interview with Pharma Commerce Editor Nicholas Saraceno, Chris ODell, Turquoise Healths SVP of market solutions, discusses the biggest challenges healthcare organizations currently face in terms of price transparency.
Pharmaceutical Technology
APRIL 14, 2025
Additional melanoma patients will have access to Scancells DNA vaccine as part of an ongoing clinical trial.
Advertisement
What if you could help your sellers stop wasting 72% of their day on non-selling activities and focus on bringing in revenue? Incorporating AI in your enablement workflows can help you cut down on busy work, get projects done faster, and let your team (and you!) focus on making a bigger impact. We put together this guide to show you how to use AI to cut time and costs for projects, including collateral creation, development of training videos, and automating tedious processes.
Pharmaceutical Commerce
APRIL 14, 2025
Steffen Lang, president, operations, executive committee member, Novartis, discusses what to expect from Novartis over the next decade in terms of technological innovations.
PharmExec
APRIL 14, 2025
OncLive serves as the connection to oncology, including groundbreaking cancer news and interviews with top oncologists in multimedia formats.
Pharmaceutical Commerce
APRIL 14, 2025
Business strategies and top news in the biotech / biopharma industry, including market access, supply chain distribution and more.
Expert insights. Personalized for you.
277 
Let's personalize your content